July 24, 2025 - Cognizant's AI Lab has achieved a major milestone, securing its 59th US patent while earning a Gold Award at the Genetic and Evolutionary Computation Conference (GECCO). The latest patents focus on multi-objective coevolution of deep neural networks and medical image classification, demonstrating advancements in model efficiency and healthcare applications. This follows the lab's open-sourcing of key AI development platforms earlier this year, underscoring its commitment to collaborative innovation.
The patents address critical challenges in AI development, including resource optimisation and cross-domain applicability. Babak Hodjat, CTO of AI at Cognizant, noted: 'These milestones reflect our deep commitment to pioneering transformative AI technologies'. The multi-objective coevolution method enables simultaneous optimisation of model performance and computational efficiency, with applications ranging from medical diagnostics to natural language processing.
This achievement aligns with broader industry trends toward open-source collaboration and patent-driven innovation. As AI adoption accelerates, companies are increasingly prioritising intellectual property to secure competitive advantages. Cognizant's approach combines proprietary R&D with community-driven development, a strategy gaining traction in sectors like healthcare and finance where ethical AI deployment is paramount.
Our view: These patents highlight the dual imperative of innovation and responsibility in AI development. While technical breakthroughs drive progress, the ethical implications of medical AI applications require rigorous governance frameworks. Cognizant's open-source initiatives demonstrate a balanced approach to fostering innovation while maintaining accountability.
Be the first to comment!